Повысь уровень инвестиционной грамотности и стань профессионалом с курсами от Societe Financiers!Подробнее

Marker Therapeutics logo
Marker Therapeutics MRKR
€ 0.90 -9.09%

Geschäftsbericht 2024
hinzugefügt 31.03.2025

report update icon

Marker Therapeutics Kennzahlen 2011-2025 | MRKR

Kennzahlen Jährlich Marker Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.0 -1.3 -0.5 -0.2 -3.1 -5.7 -0.7 -3.2 -11.8 -0.8 -0.1 -0.4 -1.8 -3.6

P/S

1.7 3.3 1.8 5.9 192.8 573.1 512.5 - - - - - - -

EPS

-1.2 -0.9 -3.6 -5.5 -0.6 -0.5 -7.8 -1.2 -0.4 -9.3 -2 -4.9 -9.4 -0.0

EV (Enterprise Value)

-4.68 M -1.2 M 19.2 M -10.9 M 86.9 M 80.5 M 46.6 M 31.5 M 22.8 M 47.4 M 3.89 M 11.1 M 16.2 M 10.9 M

EBITDA per Share

-1.24 -1.66 -3.25 -4.88 -0.593 -0.488 -7.76 -1.27 -1.2 -1.68 -2.62 -28.1 -102 -68.8

EV/EBITDA

0.5 -2.5 -3.5 -0.3 -2.5 -2.6 -3.2 -0.8 -2.1 -2.1 -3.1

PEG

-0.01 -0.01 -0.0 -0.0 0.11 -0.06 0.0 0.01 -0.12 -0.01 -0.0 -0.01 0.01 -0.05

P/B

0.6 0.8 0.8 0.2 3.3 2.8 1.8 9.6 4.7 -1.2 -2.7 -0.3 -1.9 -2.1

P/CF

-1.0 -0.7 -0.6 -0.3 -3.1 -6.5 -7.2 -4.2 -4.4 -6.0 -1.3 -3.3 -6.7 -5.6

ROE %

-57.82 -58.61 -152.70 -95.21 -104.98 -48.60 -249.34 -300.21 -39.70 159.48 3017.00 63.10 103.38 58.63

ROA %

-48.73 -48.09 -86.95 -61.46 -62.93 -46.22 -238.09 -211.99 -31.00 -512.63 -13759.58 -7182.15 -5621.18 -596.38

ROCE %

-59.91 -103.76 -112.41 -71.47 -73.66 -50.78 -249.70 -313.82 -133.58 28.83 329.31 30.39 96.67 76.20

Current Ratio

6.4 5.6 2.3 2.8 3.8 22.8 22.1 3.4 4.6 0.2 0.2 0.0 0.0 0.1

DSO

- - - - 782.4 96.2 191.7 - - - - - - -

DIO

- - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Marker Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.26 -0.25 -0.27 - -0.34 0.29 -0.57 - -0.83 -1.11 -1.19 - -0.15 -0.13 -0.16 - -0.16 -0.14 -0.14 - -0.12 -0.12 -0.12 - -0.32 -0.41 -0.3 - -0.39 -0.22 -0.29 - -0.29 1.01 -0.81 - 7.04 -1.8 -0.03 - -0.09 0.05 -3.89 - -0.76 -0.87 -0.55 - -0.01 -0.04 -0.01 - -0.02 -0.01 -0.03

EBITDA per Share

- - - - - - -0.4 - -0.46 -0.49 -1.11 - -0.1 -0.12 -0.15 - -0.15 -0.13 -0.14 - -0.12 -0.13 -0.12 - -0.32 -0.39 -0.3 - -0.39 -0.28 -0.29 - -0.37 -0.41 -0.3 - -0.43 -0.03 -0.04 - - - - - -0.25 -0.67 -1.12 - -0.01 -0.05 -0.01 - -0.02 -0.02 -0.02

ROE %

-91.73 -78.59 -42.78 -35.85 -66.46 -79.23 -125.43 -91.36 -115.13 -108.29 -92.55 -53.13 -80.09 -83.27 -89.22 -73.87 -86.25 -71.68 -61.12 -37.08 -44.48 -39.49 -34.97 -20.89 -129.84 -231.40 -275.04 -226.86 -260.86 -185.92 -37.56 -14.21 -147.65 -247.08 -61.77 151.75 304.91 591.51 236.00 2981.68 3005.14 2875.44 2958.98 1004.35 1004.35 1022.98 1055.14 94.08 76.39 100.79 70.39 72.72 24.40 11.69 36.63

ROA %

-72.22 -66.37 -36.13 -21.62 -38.45 -39.98 -69.11 -52.53 -69.81 -70.26 -66.14 -40.77 -56.93 -55.81 -56.16 -44.28 -56.06 -51.67 -49.79 -35.27 -42.33 -37.61 -33.34 -19.95 -96.88 -166.76 -195.56 -160.19 -186.74 -136.36 -24.39 -11.09 417.83 873.30 752.26 337.68 337.68 -45.62 -13281.30 -26471.37 -27842.43 -15977.81 -61920.13 -93255.69 -93255.69 -48853.03 -51763.74 -6506.51 -3843.96 -4092.12 -1300.27 -739.63 -248.16 -118.86 -372.60

ROCE %

- - -18.95 -37.91 -57.44 -58.02 -71.58 -54.05 -69.78 -65.98 -67.00 -40.74 -59.55 -62.63 -64.26 -51.97 -64.71 -58.65 -55.67 -38.69 -46.16 -40.87 -35.51 -20.73 -129.79 -231.38 -288.93 -240.55 -284.56 -219.51 -193.30 -111.58 -103.45 -51.30 -6.76 18.28 18.28 10.14 4.81 - 3.57 7.15 14.85 23.99 37.18 46.79 91.02 76.24 102.39 115.36 83.69 78.22 26.15 20.27 31.80

Current Ratio

3.1 5.9 6.1 5.6 7.0 7.5 2.3 2.3 2.2 2.1 2.9 2.8 3.7 4.7 5.6 2.5 2.5 2.5 2.5 20.4 20.4 20.4 20.4 22.2 22.2 22.2 22.2 3.4 3.4 3.4 3.4 4.6 4.6 4.6 4.6 - - - - - - - - - - - - - - - - - 0.1 0.2 -

DSO

- - - - - - - - - - - - - - - - - 2.7 - - - - - - - 47.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - 2.7 - - - - - - - 47.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - - - - - - 2.7 - - - - - - - 47.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung